Bone mineral density in Marfan syndrome. A large case-control study
- PMID: 17056292
- DOI: 10.1016/j.jbspin.2006.01.026
Bone mineral density in Marfan syndrome. A large case-control study
Abstract
Objective: To measure bone mineral density (BMD) in a group of patients meeting Gand criteria for Marfan syndrome, comparatively with a group of healthy controls.
Methods: Dual-energy X-ray absorptiometry (DEXA) was used to measure BMD at the hip and wrist in 130 patients seen at the Multidisciplinary Marfan Clinic, Paris, France. Results were compared to values in the database of the absorptiometry machine (Hologic QDR100) and to values in 72 healthy height-matched controls including 35 whose body mass index (BMI) values were similar to those in the patients.
Results: A history of fractures was noted in 32 (24.6%) patients. Z-score values were significantly decreased in the patients compared to the Hologic database values at the femoral neck (-1.190+/-0.098, P<0.0001) and wrist (-1.403+/-1.06; P < 0.001). Patients had significantly lower BMD values at the femoral neck compared to the height-matched controls (0.841+/-0.15 versus 1.010+/-0.017; P<0.0001). BMD values were also significantly lower in the patients compared to the controls of similar height and BMI. BMD values did not correlate with history of fractures or acetabular protrusion. In the patients, BMD values lower than -2.5 correlated with presence of dural ectasia.
Conclusion: Men and women with Marfan syndrome have significant osteopenia independent from BMI.
Similar articles
-
Bone mineral density in adults with Marfan syndrome.Rheumatology (Oxford). 2000 Mar;39(3):307-9. doi: 10.1093/rheumatology/39.3.307. Rheumatology (Oxford). 2000. PMID: 10788540
-
Bone mineral density in sixty adult patients with Marfan syndrome.Osteoporos Int. 1999;10(6):475-9. doi: 10.1007/s001980050257. Osteoporos Int. 1999. PMID: 10663348
-
Bone mineral status of women with Marfan syndrome.Am J Med. 1993 Dec;95(6):568-72. doi: 10.1016/0002-9343(93)90351-o. Am J Med. 1993. PMID: 8259773
-
Assessment of bone mineral density in adults and children with Marfan syndrome.Osteoporos Int. 2003 Jul;14(7):559-63. doi: 10.1007/s00198-003-1433-0. Epub 2003 Jul 3. Osteoporos Int. 2003. PMID: 12845424
-
Decreased bone mineral density in Costello syndrome.Mol Genet Metab. 2014 Jan;111(1):41-5. doi: 10.1016/j.ymgme.2013.08.007. Epub 2013 Aug 16. Mol Genet Metab. 2014. PMID: 24246682
Cited by
-
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.J Bone Miner Res. 2013 Dec;28(12):2476-89. doi: 10.1002/jbmr.1992. J Bone Miner Res. 2013. PMID: 23703870 Free PMC article.
-
Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies.Diagnostics (Basel). 2023 Jul 5;13(13):2284. doi: 10.3390/diagnostics13132284. Diagnostics (Basel). 2023. PMID: 37443678 Free PMC article. Review.
-
Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation.J Bone Miner Res. 2010 Oct;25(10):2165-74. doi: 10.1002/jbmr.105. J Bone Miner Res. 2010. PMID: 20499351 Free PMC article.
-
Power of deep, all-exon resequencing for discovery of human trait genes.Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3871-6. doi: 10.1073/pnas.0812824106. Epub 2009 Feb 6. Proc Natl Acad Sci U S A. 2009. PMID: 19202052 Free PMC article.
-
Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.J Cell Sci. 2013 Sep 15;126(Pt 18):4187-94. doi: 10.1242/jcs.127571. J Cell Sci. 2013. PMID: 24039232 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
